Small airway dysfunction as predictor and marker for clinical response to biological therapy in severe eosinophilic asthma: a longitudinal observational study

BACKGROUND: Anti-T2 biological therapies have proven to effectively reduce acute exacerbations and daily doses of oral steroids in severe eosinophilic asthma. Despite the remarkable clinical efficacy, there are usually only moderate improvements in airflow limitation, suggesting that other measures...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdo, Mustafa, Watz, Henrik, Veith, Vera, Kirsten, Anne-Marie, Biller, Heike, Pedersen, Frauke, von Mutius, Erika, Kopp, Matthias V., Hansen, Gesine, Waschki, Benjamin, Rabe, Klaus F., Trinkmann, Frederik, Bahmer, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579879/
https://www.ncbi.nlm.nih.gov/pubmed/33087134
http://dx.doi.org/10.1186/s12931-020-01543-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579879/
https://www.ncbi.nlm.nih.gov/pubmed/33087134
http://dx.doi.org/10.1186/s12931-020-01543-5

Ejemplares similares